Editor鈥檚 Note: Have a question for the Inside EMS hosts or an idea for an upcoming show? Drop us a line at theshow@ems1.com and be sure to follow for exclusive content, in-depth analysis and original videos.
This week on Inside EMS, our cohosts discuss a recent study out of UC Davis Health that highlights the benefits of using naloxone in opioid-associated out-of-hospital cardiac arrest response. Chris and Kelly discuss the results and debate how this knowledge could impact OHCA protocols.
Top takeaways: 鈥業t鈥檚 going to change my practice鈥�
- 鈥淚f you look at the 鈥� survival of hospital discharge, the number needed to treat was 26. So 1 in 26 patients you would do this to has a chance of surviving the hospital discharge. That鈥檚 pretty compelling. It鈥檚 going to change my practice.鈥� 鈥� Kelly Grayson
- 鈥淚t鈥檚 obviously needed information considering how bad the opioid overdose epidemic is in the United States. The numbers are compelling 鈥� the fact that this affects so many of our out-of-hospital cardiac arrests and that this actually shows pretty strong evidence of improved outcome.鈥� 鈥� Kelly Grayson
- 鈥淲e think about over the past 20 years, and now with fentanyl being part of that process, we鈥檙e starting to see a lot more [drug-related cardiac arrests] and there鈥檚 an urgent need for this evidence that allows us to now figure out if Narcan can make a difference in OHCAs.鈥� 鈥� Chris Cebollero
| ENJOYING THE SHOW? LEAVE US A REVIEW!
Catch a new episode every Friday on鈥�,鈥�,鈥�,鈥�,鈥�,鈥�, and鈥�.
This episode of Inside EMS is brought to you by Lexipol, the experts in policy, training, wellness support and grants assistance for first responders and government leaders. To learn more, visit鈥�.
